Clinicopathological and Demographic Factors Associated with Development of Distant Metastasis among Patients with Locoregional Neuroendocrine Tumor (NET).

A. Dasari,Daniel M. Halperin,Shouhao Zhou,Yiyi Chu,Ying Xu,Tina Shih,James C. Yao,Chan Shen

DOI: https://doi.org/10.1200/jco.2016.34.15_suppl.4099

IF: 45.3

2016-01-01

Journal of Clinical Oncology

Abstract:4099 Background: Incidence oflocoregional NETs is increasing. However, the association between the risk of development of metastasis and clinicopathological/demographic factors remains poorly understood. We assessed the association between baseline characteristics at diagnosis and risk of metastatic spread. Methods: From the Surveillance, Epidemiology and End Results (SEER)-Medicare database, we identified NET patients diagnosed between 1/2002 and 12/2011 by ICD-O-3 codes. We further restricted the study cohort to patients with locoregional disease at diagnosis. We excluded patients under age 65, without continuous Medicare Parts A and B enrollment or enrolled in health maintenance organizations. Development of metastatic disease was identified by capturing at least two claims indicative of secondary malignant neoplasms until 12/31/2013. Demographic and clinical characteristics between patients with and without development of metastasis were compared using Chi-squared tests. Time to development of metastasis was assessed using the Kaplan Meier method and compared using log rank test. Results: At the time of diagnosis, of the 5472 eligible patients, 67% had localized disease, 70% were grade 1 or 2 and were either gastroenteropancreatic (53%), pulmonary (31%) or of unknown origin (15%). During the study period, 1618 (30%) patients developed metastatic disease. We found that the risk of developing distant metastasis varied significantly by grade (22% in grade 1 to 57% in grade 4), stage at diagnosis (15% in local vs 70% in regional), and primary site (13% in colon and rectum to 44% in pancreas). The log rank tests confirmed the significant differences in disease progression by the above tumor characteristics with p-values less than 0.01. Conclusions: This is the largest population-based study to date evaluating disease progression patterns among Medicare patients over 65 years old with locoregional NETs and showed that approximately 28% of patients developed distant metastases within two years from diagnosis. Histology grade, stage at diagnosis and primary site were significantly associated with risk of development of metastatic disease.